We’re still in preliminary territory, so don’t bank on this yet. Health care M&A hit 120 deals for the month of April 2016, down 12% versus the previous month’s 136 deals, but 7% better than the same month a year ago. Long-term care deals led the transaction activity with 21 deals (18% of the total), with Biotechnology (17 deals, 14%) and eHealth (16 deals, 13%) close behind.
Thanks to the $30.7 billion Abbott (NYSE: ABT) offer for St. Jude Medical (NYSE: SJM), spending for the month was far higher than in recent months. April’s deal value now stands at $42.2 billion, up 240% compared with March’s $12.4 billion and 732% compared with April 2015’s $5.1 billion.
Take out that single mega-deal, and the picture changes dramatically. April’s total would only come to $11.5 billion, down 8% compared with March, and up “just” 127% compared with a year ago. We’ll have the rest of the sectors and analysis in the May issue of Health Care M&A News, so watch for your copy in your inbox.
